NR4A1 and breast cancer: For aggressive breast cancer subtypes that achieve a pCR, the risk of death has been shown to decrease by 84% in TNBC, 92% in HER2+, and 71% in grade 3 hormone receptor positive/HER2-negative breast cancers in the CTNeoBC pooled analysis [7].